Research to Further Inform Thinking About the Role of LINX for Reflux Disease
The RETHINK REFLUX Registry is a post-market prospective, multi-center, observation, single arm, long-term safety surveillance registry of subjects implanted with the LINX device. The primary objective of the study is to confirm the long-term safety profile of the LINX device and procedure (implant/explant) up to 10 years post-implant.
NCT04253392 — Gastroesophageal Reflux
Status: Active, not recruiting
http://inclinicaltrials.com/gastroesophageal-reflux/NCT04253392/
Evaluate the Intestinal Microbiome in Patients With Erosive Gastroesophageal Reflux Disease and in Asymptomatic Healthy Controls
. In this study, we investigated intestinal microbiomes, in individuals with Gastroesophageal Reflux Disease and healthy individuals, using metagenomic techniques.
NCT04248296 — Gastroesophageal Reflux Disease With Esophagitis
Status: Completed
http://inclinicaltrials.com/gastroesophageal-reflux-disease-with-esophagitis/NCT04248296/
ENDOSCOPIC ANTI REFLUX MUCOSAL ABLATION THERAPHY (ARMA) FOR THE TREATMENT OF PROTON PUMP INHIBITOR DEPENDENT GASTRO ESOPHAGEALREFLUX DISEASE: OPEN LABEL SINGLE CENTER OBSERVATIONAL STUDY
OBJECTIVES To study the safety and efficacy of Endoscopic Anti Reflux Mucosal Ablation (ARMA) procedure for the treatment of proton pump inhibitor (PPI) dependent gastro-esophageal reflux disease (GERD) DESIGN OF THE Prospective interventional study Sample size: 216
NCT04243668 — GERD
Status: Completed
http://inclinicaltrials.com/gerd/NCT04243668/
Long Term Incidence and Effect of Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy in Chinese Population
To evaluate the long-term incidence and effects of gastroesophageal reflux disease in the Chinese population after laparoscopic sleeve gastrectomy.
NCT04237857 — Gastroesophageal Reflux
Status: Recruiting
http://inclinicaltrials.com/gastroesophageal-reflux/NCT04237857/
Phase II Clinical Study on the Safety and Efficacy of Antireflux Mucosectomy (ARMS) for Treatment of Gastroesophageal reflux
This is a phase II clinical study to investigate the safety and efficacy of endoscopic antireflux mucosectomy (ARMS) for treatment of GERD.
NCT04194723 — Gastro Esophageal Reflux
Status: Recruiting
http://inclinicaltrials.com/gastro-esophageal-reflux/NCT04194723/
Long-term Follow-up of Patient Satisfaction, Reflux Control and Gastrointestinal Disorders in Patients Undergoing Laparoscopic Surgical Treatment for GERD, With Partial or Total Fundoplication
10 years of follow-up with SF-36 global (Quality of Life issues), GSRS (Gastrointestinal Symptom Rating Scale) and two reflux specific questionnaires.
NCT04182178 — Dysphagia
Status: Completed
http://inclinicaltrials.com/dysphagia/NCT04182178/
Effectiveness of Diaphragmatic Breathing on Reflux Symptoms in Outpatients.
Researchers are trying to determine if abdominal breathing exercises can reduce symptoms associated with GERD (Gastroesophageal reflux disease).
NCT04120025 — GERD
Status: Completed
http://inclinicaltrials.com/gerd/NCT04120025/
Does Gastric Reflux Induce Sinonasal Symptoms?
The study is conducted to: - study correlation between sinonasal troubles & GERD - Assess whether antireflux therapy improve state of sinus in patients complaining from reflux & sinonasal symptoms
NCT04105894 — Gastro Esophageal Reflux
Status: Not yet recruiting
http://inclinicaltrials.com/gastro-esophageal-reflux/NCT04105894/
Epi-GERD Study: Epidemiological Evaluation in Patients With Gastro-Esophageal Reflux
Cross-sectional epidemiological study in patients with diagnosis of GERD (Gastroesophageal Reflux Disease) and with current treatment or with a history of recent treatment with some PPI (Proton Pump Inhibitor), in order to evaluate the persistence and / or relapse of symptoms of GERD.
NCT04094402 — Gastroesophageal Reflux Disease
Status: Recruiting
http://inclinicaltrials.com/gastroesophageal-reflux-disease/NCT04094402/
Safety and Efficacy of Antireflux Ablation Therapy (ARAT) at Esophagogastric Junction in Patients With reflux Disease After Peroral Endoscopic Myotomy (POEM) in Achalasia
The peroral endoscopic myotomy for the treatment of achalasia is associated with a higher incidence of gastroesophageal reflux disease compared with Heller's myotomy. Remodeling of the esophagogastric junction with hybrid argon plasma could decrease the passage of gastric or gastroduodenal content into the esophagus.
NCT04065516 — Gastroesophageal Reflux
Status: Enrolling by invitation
http://inclinicaltrials.com/gastroesophageal-reflux/NCT04065516/